Lipella Pharmaceuticals INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
OTC.Pink
SCHEDULE 13G/A: Leaf Huang Reduces Stake in Lipella Pharmaceuticals Below 5%
Leaf Huang has filed an Amendment No. 3 to Schedule 13G, indicating a reduction in beneficial ownership of Lipella Pharmaceuticals Inc. common stock to 2.7%, ceasing to be a 5% beneficial owner.
OTC.Pink
Sabby Management, LLC, Sabby Volatility Warrant Master Fund Ltd, and Hal Mintz have jointly reported a 4.9% beneficial ownership stake in Lipella Pharmaceuticals Inc. common stock as of December 31, 2024.